MarketBeat
06 Nov 2026, 06:16 UTC · 1h ago
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call
Impact · against what's priced in
Health Catalyst faces significant fundamental deterioration, most notably a collapse in professional services margins to 1.7% and an expected Q4 EBITDA loss of up to $1.8 million. While bookings growth and the termination of an unprofitable contract provide minor offsets, the admission of higher-than-desired churn under new leadership suggests a precarious growth trajectory.
- HCAT−0.30
No priced-in read yet
- In context
The company's professional services margins crashed to 1.7%, contributing to an adjusted gross margin drop to 44.3% from 52.6% a year ago. Additionally, the forecast of a Q4 adjusted EBITDA loss of $1.3 million to $1.8 million marks a sharp sequential decline from the Q3 profit of $779k.
